Frontlight ResearchEarly access
Trial site
Interbalkan Hospital of Thessaloniki
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis2 trials
- Kidney cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 34 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2 trials
- Daiichi Sankyo1 trial
- Eisai Inc.1 trial
- Gilead Sciences1 trial
- Pierre Fabre Medicament1 trial
Running trials
Recruiting
Active, not recruiting
Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026